Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and Co | Buenos Aires | Healthcare | Pharmaceuticals | ARS 686.78T | 126.3x | 15.84 | ARS 18,950 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
UnitedHealth Group | Buenos Aires | Healthcare | Healthcare Providers & Services | ARS 478.43T | 37x | -1.13 | ARS 22,775 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Johnson & Johnson DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 359.44T | 10.3x | 0.11 | ARS 14,075 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Johnson Johnson DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 357T | 22.7x | ARS 1,580 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Johnson & Johnson | Buenos Aires | Healthcare | Pharmaceuticals | ARS 343.94T | 9.9x | 0.28 | ARS 815 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Abbvie | Buenos Aires | Healthcare | Pharmaceuticals | ARS 298.86T | 60.9x | -2.51 | ARS 24,400 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Merck & Co DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 295.14T | 138.4x | -1.68 | ARS 33,050 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
AstraZeneca PLC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 225.89T | 37.6x | 1.13 | ARS 51,600 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Thermo Fisher Scientific | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 210.75T | 35.6x | 20.65 | ARS 36,250 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Novartis DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 207.12T | 22.1x | 0.18 | ARS 36,350 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Abbott Laboratories | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 169.59T | 32.9x | 3.89 | ARS 34,675 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Amgen | Buenos Aires | Healthcare | Pharmaceuticals | ARS 166.34T | 47.6x | -0.9 | ARS 14,625 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Pfizer DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 161.98T | -559.1x | 5.79 | ARS 10,150 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bristol-Myers Squibb DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 94.76T | -16.8x | 0.08 | ARS 22,100 | 10.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Medtronic | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 93.59T | 28.5x | -12.97 | ARS 25,900 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Gilead Sciences | Buenos Aires | Healthcare | Pharmaceuticals | ARS 89.15T | 198.5x | -2.05 | ARS 25,375 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
GSK plc DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 75.77T | 14.1x | -0.2 | ARS 13,175 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Biogen AR | Buenos Aires | Healthcare | Pharmaceuticals | ARS 28.58T | 26.3x | -0.45 | ARS 21,425 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Koninklijke Philips DRC | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 22.46T | -27.4x | -0.46 | ARS 6,800 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Cardinal Health | Buenos Aires | Healthcare | Pharmaceuticals | ARS 21.92T | 43.8x | 1.57 | ARS 43,325 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Laboratorios Richmond | Buenos Aires | Healthcare | Pharmaceuticals | ARS 75.10B | -17.8x | 0.01 | ARS 930 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Instituto Rosenbusch | Buenos Aires | Healthcare | Pharmaceuticals | ARS 4.10B | 4.1x | 0.01 | ARS 96.30 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |